Physiologic Comparison Between NIV-NAVA and PS in Preterm Infants
- Conditions
- Noninvasive Neurally Adjusted Ventilatory Assist and Pressure Support in Preterm Infants
- Interventions
- Device: noninvasive respiratory support with NAVA mode and PSV
- Registration Number
- NCT01877720
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Neurally adjusted ventilatory assist (NAVA) has been shown to improve patient- ventilator interaction and reduce asynchronies. This is a short-term physiologic comparison between PSV (pressure support ventilation) and NAVA in delivering noninvasive ventilation through a nasal cannula, in premature infants postextubation. Patients will undergo a 30-min crossover trial of noninvasive PSV and NAVA, 15 minutes each. Diaphragm electrical activity (EAdi)and airway pressure (Paw) are recorded to derive neural and mechanical respiratory rate and timing, inspiratory trigger delays time of synchrony between diaphragm contraction and ventilator assistance, and the asynchrony index (AI).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
- preterm infants less than 32 weeks of gestational age
- intubated more than 48 hours after birth
- subjected to extubation with minimal ventilator setting (mean airway pressure < 7cmH2O + peak inspiratory pressure < 13 cmH2O + FiO2 < 0.4 + respiratory rate < 35/min)
- with informed consent from parents
- with major congenital anomalies
- use of sedative or anesthetic drugs
- hemodynamic instability
- grade 3 or higher intraventricular hemorrhage
- phrenic nerve palsy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description NAVA-PS noninvasive respiratory support with NAVA mode and PSV noninvasive NAVA first for 15 minutes and then PSV for 15 minutes PS-NAVA noninvasive respiratory support with NAVA mode and PSV noninvasive PSV first for 15 minutes and then NAVA for 15 minutes
- Primary Outcome Measures
Name Time Method Trigger Delay last 5-min of each 15-min trial Inspiratory trigger delay could be calculated by the time interval between beginning of the increase of actual diaphragmatic excitation and start of ventilator inspiratory flow of each respiration. The value will be present as a mean of all inspiratory trigger delay measurements of all respiration during last 5 minutes of each 15 minutes trial.
- Secondary Outcome Measures
Name Time Method Ti_excess (Inspiratory Time in Excess) last 5-min of each 15-min trial Ti_excess = (VPT-NIT)/NIT
VPT: ventilator pressurization time (VPT) between beginning and end of inspiratory flow NIT: neural inspiratory time (NIT) between beginning of the increase in the diaphragmatic excitation and its maximal valueHeart Rate last 5-min of each 15-min trial Pneumatic Respiratory Rate last 5-min of each 15-min trial Leakage last 5-min of each 15-min trial \[TVi (inspiratory tidal volume) - TVe (expiratory tidal volume)\]/TVi (inspiratory tidal volume)
Blood Pressure last 5-min of each 15-min trial systolic, diastolic and mean blood pressure measured by non-invasive cuff
SpO2 last 5-min of each 15-min trial transcutaneous peripheral saturation of oxygen by pulse oximeter
Respiratory Rate last 5-min of each 15-min trial Minute Ventilation Volume last 5-min of each 15-min trial inspiratory tidal volume / respiratory rate
Peak Inspiratory Pressure last 5-min of each 15-min trial Maximum EAdi last 5-min of each 15-min trial Swing EAdi last 5-min of each 15-min trial All Asynchrony Events last 5-min of each 15-min trial Asynchrony Index last 5-min of each 15-min trial total number of each event per minute
1. ineffective efforts: presence of a characteristic EAdi (electrical activity of diaphragm) activity not followed by a ventilator delivered pressurization
2. auto-triggering: a cycle delivered by the ventilator without EAdi signal
3. premature cycling
4. delayed cycling: VPT \> NIT x2
5. double triggering
* Asynchrony index = \[(1)+(2)+(3)+(4)+(5)\]/\[(1)+pneumatic respiratory rate\] x100
Trial Locations
- Locations (3)
Seoul National University Children's Hospital
🇰🇷Seoul, Korea, Republic of
Seoul National University Bundang Hospital
🇰🇷Bundang, Gyeonggi-do, Korea, Republic of
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of